Trials / Unknown
UnknownNCT05718076
Trifocal Intraocular Lens in High Myopic Patients With Different Meta-PM Grading
A Prospective, Observational Study to Investigate Visual Outcome After Trifocal Intraocular Lens Implantation in High Myopic Patient With Different Meta-PM Grading Fundus Appearance.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Aier School of Ophthalmology, Central South University · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Study the postoperative visual quality and safety of trifocal intraocular lenses implanted in patients with different levels of myopic maculopathy stages according to Meta-PM staging (stage 0-2).
Detailed description
Cataracts occur in patients with high myopia who are younger than age related cataract patients. These relatively young cataract patients have a higher demand for lens removal, and therefore have a higher acceptance of multifocal intraocular lenses. Some current studies have shown that the implantation of multifocal intraocular lenses in patients with high myopia has achieved good visual effects after surgery. As we all know, high myopia is associated with a higher incidence of postoperative complications, and high myopia macular degeneration can affect postoperative visual effects and patient satisfaction. However, there is no research to evaluate the clinical effect of multifocal intraocular lens implantation in patients with high myopia according to different fundus Meta-PM classifications.Therefore, the purpose of this study is to study the postoperative visual quality and safety of trifocal intraocular lenses implanted in patients with different levels of myopic maculopathy stages according to Meta-PM staging (stage 0-2).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | cataract surgery | Phacoemulsification combined trifocal lens implantation |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2023-02-08
- Last updated
- 2023-02-08
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05718076. Inclusion in this directory is not an endorsement.